by PEPID Newsroom | Nov 14, 2018 | Alerts
FDA approves a new version of Primatene Mist, the only OTC metered-dose inhaler. Primatene Mist is approved by the FDA as an OTC drug to provide temporary relief for symptoms of mild, intermittent asthma. Primatene Mist is only approved for those who have been...
by Megan Pullins | Nov 14, 2018 | Alerts
Monday, JAMA published a summarized report of the just-released U.S. Department of Health and Human Services (HHS) second edition Physical Activity Guidelines for Americans (PAG), which provides evidence-based recommendations to improve American individual and...
by PEPID Newsroom | Nov 9, 2018 | Alerts
The FDA announced emergency use authorization for a rapid, single-use test to detect the Ebola Virus (Zaire ebolavirus). The test, called the DPP Ebola Antigen System (Chembio Diagnostic Systems Inc), is novel for using a portable battery reader for accurate...
by PEPID Newsroom | Nov 9, 2018 | Alerts
A French study finds an association between a higher frequency of organic food consumption and a reduced risk of cancer. The study findings still need to be confirmed. In this population-based cohort study of 68,947 French adults, high organic food scores were...
by Anna Tan | Nov 8, 2018 | Pharmacy
Moving Forward with Remote SupportThe intimidating costs behind patient-centered healthcare reform can be mitigated with the added revenue and reduced labor costs of establishing remote pharmacy models (RPMs). These highly efficient sites not only give operational...
by PEPID Newsroom | Nov 7, 2018 | Alerts
A cohort study by the United Kingdom Clinical Research Datalink associated the use of ACEIs with an increased risk of lung cancer. The association elevated among people using ACE Inhibitors for more than five years. The study consisted of 992,061 patients treated with...
by pepidwpblog | Nov 5, 2018 | Press & Media
For Immediate Release: September 15, 2017 — Phoenix, AZ Statement: PEPID, LLC, the leading developer of point-of-care clinical decision support solutions, will be participating in the ASHP Midyear 2018 Clinical Meeting and Exhibition as an exhibitor at booth...
by PEPID Newsroom | Nov 2, 2018 | Alerts
Yesterday, November 1st, the federal Centers for Medicare & Medicaid Services (CMS) published their final rule for the Physician Fee Schedule for CY 2019, and Quality Payment Program (QPP)—regarding the Patients Over Paperwork Initiative, E&M requirements,...
by PEPID Newsroom | Nov 1, 2018 | Alerts
23andMe is the first direct-to-consumer (DTC) genetic test to be permitted by the FDA to market their pharmacogenomic reports providing information regarding genetic variants that may be associated with a patient’s ability to metabolize some medications to help inform...
by Anna Tan | Nov 1, 2018 | Pharmacy
Moving Forward with New Provisions The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R. 6), signed on October 24, 2018, addresses the opioid crisis by reducing supply and access while...
